Evidence-based treatment of herpes simplex virus keratitis: A systematic review

Ocular Surface

Volumn 5, Issue 3, 2007, Pages 240-250

  Guess, Scott ^a,b   Stone, Donald U ^a,b   Chodosh, James ^a,b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Acyclovir; Epithelial keratitis; Evidence based medicine; Herpes simplex virus; Keratitis; Randomized clinical trial; Stromal keratitis; Trifluridine

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ALPHA INTERFERON; ALPHA2C INTERFERON; ANTIVIRUS AGENT; BECLOMETASONE; CORTICOSTEROID; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; FLURBIPROFEN; FOSCARNET; IDOXURIDINE; INTERFERON; PLACEBO; PREDNISOLONE SODIUM PHOSPHATE; TRIFLURIDINE; VIDARABINE; EYE DROPS;

ANTIVIRAL THERAPY; CAUTERIZATION; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CORNEA EPITHELIUM; CORNEA STROMA; CORTICOSTEROID THERAPY; DEBRIDEMENT; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; EVIDENCE BASED PRACTICE; HERPES SIMPLEX KERATITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MEDICAL LITERATURE; MEDLINE; MONOTHERAPY; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT VIRUS INFECTION; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; EVIDENCE BASED MEDICINE; METHODOLOGY;

ANTIVIRAL AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; KERATITIS, HERPETIC; OPHTHALMIC SOLUTIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 38449106082     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70614-6     Document Type: Article

References (101)

1. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001;20:1-13
2. Liesegang TJ. Epidemiology and natural history of ocular herpes simplex virus infection in Rochester, Minnesota, 1950-1982. Trans Am Ophthalmol Soc 1988;86:688-724
3. Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology 2005;112;888-95
4. Lairson DR, Begley CE, Reynolds TF, Wilhelmus KR. Prevention of herpes simplex virus eye disease: a cost effectiveness analysis. Arch Ophthalmol 2005;121:108-12
5. Kaufman HE. Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine. Proc Soc Exp Biol Med 1962;109:251-2
6. Dawson CR. The herpetic eye disease study. Arch Ophthalmol 1990;108:191-2
7. Dawson CR, Jones DB, Kaufman HE, et al. Design and organization of the herpetic eye disease study (HEDS). Curr Eye Res 1991;10(S):105-10
8. Shojania KG, McDonald KM, Wachter RM, Owens DK. Closing the quality gap: A critical analysis of quality improvement strategies, volume I - Series overview and methodology. Technical Review 9 (Contract No. 290-02-0017 to the Stanford University-UCSF Evidence-based Practice Center). AHRQ Publication No. 04-0051-1. Rockville, MD: Agency for Healthcare Research and Quality. August 2004.
9. Whitley RJ. Herpes simplex viruses, in Fields BN, Knipe DM, Howley PM, et al (eds). Fields Virology, 3rd edition. Philadelphia, Lippincott-Raven Publishers, 1996, pp 2297-342
10. Darougar S, Wishart MS, Viswalingam ND. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol 1985;69:2-6
11. (No authors listed). Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group. Arch Ophthalmol 2000;118:1617-25
12. Prabriputaloong T, Margolis TP, Lietman TM, et al. Atopic disease and herpes simplex eye disease: a population-based case-control study. Am J Ophthalmol 2006;42:745-9
13. Hodge WG, Margolis TP. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epiderniologic study. Ophthalmology 1997;104:120-4
14. Wishart MS, Darougar S, Viswalingam ND. Recurrent herpes simplex virus ocular infection: epidemiological and clinical features. Br J Ophthalmol 1987;71:669-72.
15. Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-9
16. Khan BF, Pavan-Langston D. Clinical manifestations and treatment modalities in herpes simplex virus of the ocular anterior segment. Int Ophthalmol Clin 2004;44:103-33
17. Wilhelmus KR, Coster DJ, Donovan HC, et al. Prognosis indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration. Arch Ophthalmol 1981;99:1578-82
18. Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea 1999;18:144-54
19. Chodosh J. Viral keratitis, in Parrish RK. Bascom Palmer Atlas of Ophthalmology. Boston, Current Medicine, 2000, pp 64-70
20. Holbach LM, Font RL, Naumann GO. Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet's membrane, the stroma, and Bowman's layer. Ophthalmology 1990;97:722-8
21. Holbach LM, Font RL, Baehr W, Pittler SJ. HSV antigens and HSV DNA in avascular and vascularized lesions of human herpes simplex keratitis. Curr Eye Res 1991;10 Suppl:63-8
22. Metcalf JF, Hamilton DS, Reichert RW. Herpetic keratitis in athymic (nude) mice. Infect Immun 1979;26:1164-71
23. Hendricks RL, Tumpey TM, Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol 1992;149:3023-8
24. Hendricks RL. An inununologists view of herpes simplex keratitis: Thygeson Lecture 1.996, presented at the Ocular Microbiology and Immunology Group Meeting, October 26, 1996. Cornea 1997;16:503-6
25. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 1997;18:443-9
26. Coster DJ, Falcon MG, Cantell K, Jones BR. Clinical experience of human leucocyte interferon in management of herpetic keratitis. Trans Ophthalmol Soc UK 1977;97:327-9
27. Klauber A, Ottovay E. Acyclovir and idoxiuridine treatment of herpes simplex keratitis- A double-blind clinical study. Acta Ophthalmol 1982;60:838-44
28. Simon AL, Pavan-Langston D. Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 1996;103:1399-405
29. Schwab IR. Oral acyclovir in the management of herpes simplex ocular infection. Ophthalmology 1988;95:423-30
30. Colin J, Hoh HB, Easty DL, et al. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. Cornea 1997;16:393-9
31. Fulhorst HW, Richards AB, Bowbyes J, Jones BR. Cryotherapy of epithelial herpes simplex keratitis. Am J Ophthalmol 1972;73:46-51
32. Hoh HB, Hurley C, Claoue C, et al. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. Br J Ophthalmol 1996;80:140-3
33. Jensen KB, Nissen SH, Jessen F. Acyclovir in the treatment of herpetic keratitis. Acta Ophthalmol 1982;60:557-63
34. Parlato CJ, Cohen Ej, Sakauye CM, et al. Role of debridement and trifluridine (trifluorothrymidine) in herpes simplex dendritic keratitis. Arch Ophthalmol 1985;103:673-5
35. Pavan-Langston D, Foster CS. Trifluorothymidine and idoxuridine therapy of ocular herpes. Am J Ophthalmol 1977;84:818-25
36. Shimomura Y, Ohashi Y, Maeda N, et al. Herpetic keratitis therapy to reduce recurrence. Curr Eye Res 1987;6:105-10
37. Sozen E, Avunduk AM, Akyol N. Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial. Chemotherapy 2006;52:29-31
38. Tarakji MS, Matta CS, Shammas HF. Cryotherapy of herpes simplex keratitis. Ann Ophthalmol 1978;10:1557-9
39. Vannini A, Cembrano S, Assetto V, Giannitelli A. Interferon-beta treatment of herpes simplex keratitis. Ophthalmologica 1986;192:6-10
40. Wilhelmus KR, Coster DJ, Jones BR. Acyclovir and debridement in the treatment of ulcerative herperic keratitis. Am J Ophthalmol 1981;91:323-7
41. Sugar j, Stark NA, Binder PS, et al. Trifluorothymidine treatment of herpes simplex epithelial keratitis and comparison with idoxuridine. Ann Ophthalmol 1980;12:611-5
42. Shiota H, Nitta K, Naito T, et al. Clinical evaluation of carbocyclic oxetanocin G eyedrops in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol 1996;80:413-5
43. Blake J, Browne M. Treatment of herpetic keratitis. Doc Ophthalmol 1977;44:23-33
44. Panda A, Das GK, Khokhar S, Rao V. Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis. Can J Ophthalmol 1995;30:256-8
45. Burns RP. A double-blind study of idoxuridine in human herpes simplex keratitis. Arch Ophthalmol 1963;70:141-4
46. Jones BR, Coster DJ, Falcon MG, Cantell K. Clinical trials of topical interferon therapy of ulcerative viral keratitis. J Infect Dis 1976;133(S):173-7
47. Laibson PR, Leopold IH. An evaluation of double-blind idoxuridine therapy in 100 cases of herpetic keratitis. Trans Am Acad Ophthalmol Otolarnyngol 1964;68:22-34
48. Pavan-Langston D, Buchanan R. Vidarabine therapy of simple and idoxuridine-complicated herpetic keratitis. Trans Ophthalmol Am Acad Ophthalmol Otolaryngol 1976;81:813-25
49. de Koning EW, van Bijsterveld OP, Cantell K. Combination therapy for dendritic keratitis with human leukocyte interferon and trifluorothymidine. Br J Ophthalmol 1982;66:509-12
50. Kaufman HE, Meyer RF, Laibson PR, et al. Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J Infect Dis 1976; 133(S):165-8
51. McCulley JP, Binder PS, Kaufman HE, et al. A double-blind, multicenter clinical trial of acyclovir vs idoxuridine for treatment of epithelial herpes simplex keratitis. Ophthalmology 1982;89:1195-200
52. McGill J, Tormey P, Walker CB. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol 1981;65:610-3
53. Pavan-Langston D, Lass J, Hettinger M, Udell I. Acyclovir and vidarabine in the treatment of ulcerative herpes simplex keratitis. Am J Ophthalmol 1981;92:829-35
54. Sundmacher R, Neumann-Haefelin D, Manthey KF, Muller O. Interferon in treatment of dendritic keratifis in humans: a preliminary report. J Inf Dis 1976;133:160-4
55. van Bijsterveld OP, Post H. Trifluorothymidine versus adenine arabinoside in the treatment of herpes simplex keratitis. Br J Ophthalmol 1980;64:33-6
56. Yeakley WR, Laibson PR, Michelson MA, Arentsen JJ. A double-controlled evaluation of acyclovir and vidarabine for the treatment of herpes simplex epithelial keratitis. Trans Am Ophthalmol Soc 1981;79:168-79
57. Young BJ, Patterson A, Ravenscroft T. A randomised double-blind clinical trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex corneal ulceration. Br J Ophthalmol 1982;66:361-3
58. van Rooij J, Rijneveld WJ, Remeijer L, et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology 2003;110:1916-9
59. Cellini M, Baldi A, Caramazza N, et al. Epidermal growth factor in the topical treatment of herpetic corneal ulcers. Ophthalmologica 1994;208:37-40
60. Colin J, Chastel C, Renard G, Cantell K. Combination therapy for dendritic keratitis with human leukocyte interferon and acyclovir. Am J Ophthalmol 1983;95:346-8
61. Collum LM, McGettrick P, Akhtar J, et al. Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration. Br J Ophthalmol 1986;70:435-8
62. de Koning EW, van Bijsterveld OP Cantell K. Combination therapy for dendritic keratitis with acyclovir and alpha interferon. Arch Ophthalmol 1983;101:1866-8
63. Hung SO, Patterson A, Clark DI, Rees PJ. Oral acyclovir in the management of dendritic herpetic corneal ulceration. Br J Ophthalmol 1984;68:398-400
64. Markham RH, Carter C, Scobie MA, et al. Double-blind clinical trial of adenine arabinoside and idoxuridine in herpetic corneal ulcers. Trans Ophthalmol Soc UK 1977;97:333-40
65. van Bijsterveld OP, Meurs PJ, de Clercq E, Maudgal PC. Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study. Br J Ophthalmol 1989;73:604-7
66. Behrens-Baumann W. Phosphonoformate (foscarnet, PFA) versus trifluorothymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial. Acta Ophthalmologica 1992;70:690-2
67. Coster DJ, Jones BR, McGill JI. Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluoyothymidine. Br J Ophthalmol 1979;63:418-21
68. Hovding G. A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis. A double blind, randomized parallel group trial. Acta Ophthalmol 1989;67:51-4
69. la Lau C, Oosterhuis JA, Versteeg J, et al. Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial. Br J Ophthalmol 1982;66:506-8
70. Power WJ, Benedict-Smith A, Hillery M, et al. Randomised doubleblind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TF) in dendritic corneal ulceration. Br J Ophthalmol 1991;75:649-51
71. Wellings PC, Awdry PN, Bors FH, et al. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol 1972;73:932-42
72. Collum LM, Benedict-Smith A, Hillary IB. Randomised doubleblind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol 1980;64:766-9
73. Collum LM, Logan P, McAuliffe-Curtin D, et al. Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid coma ulceration. Br J Ophthalmol 1985;69:847-50
74. Coster DJ, Wilhelmus KR, Michaud R, Jones BR. A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis. Br J Ophthalmol 1980;64:763-5
75. Jackson WB, Breslin CW, Lorenzetti DW, et al. Treatmentof herpes simplex keratitis: comparison of acyclovir and vidarabine. Can J Ophthalmol 1984;19:107-11
76. Laibson P R, Pavan-Langston D, Yeakley WR, Lass J. Acyclovir and vidarabine for the treatment of herpes simplex keratitis. Am J Med 1982;73:281-5
77. Hung SO, Patterson A, Rees PI. Pharmcokinetics of oral acyclovir (Zovirax) in the eye. Br J Ophthalmol 1984;68:192-5
78. Wilhelmus KR. The treatment of herpes simplex virus epithelial keratitis. Trans Am Ophthalmol Soc 2000;98:505-32
79. Epstein RJ, Seedor JA, Dreizen NG, et al. Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival. Ophthalmology 1987;94:935-44
80. Collum LM, Grant DM. A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis. Curr Eye Res 1987;6:221-4
81. Gunduz K, Ozdemir O. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis. Ophthalmic Res 1997;29:405-8
82. Heiligenhaus A, Steuhl KP. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study Graefes Arch Clin Exp Ophthalmol 1999;237:435-48
83. Pivetti-Pezzi P, Accorinti M, Coloabelli-Gisoldi RA, et al. Herpes simplex virus vaccine in recurrent herpetic ocular infection 1999;18:47-51
84. Porter SM, Patterson A, Kho P. A comparison of local and systemic acyclovir irt the management of herpetic disciform keratitis. Br J Ophthalmol 1990;74:283-5
85. Collum LM, Logan P, Ravenscroft T. Acyclovir (Zovirax) in herpetic disciform keratitis. Br Ophthalmol 1983;67:115-8
86. Power WJ, Hillery MP, Benedict-Smith A, Collum LMI. Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis. Br J Ophthalmol 1992;76:711-3
87. Vajpayee RB, Dhakal BP, Gupta SK, et al. Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis. Aust N Z J Ophthalmol 1996;24:131-5
88. (No authors listed). A controlled trial of oral acydovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The epithelial keratitis trial. The Herpetic Eye Disease Study Group Arch Ophthalmol 1997;115:703-12
89. Barron BA, Gee L, Hauck WW, et al. Herpetic eye disease study A controlled trial of oral acyclovir for herpes simplex keratitis. Ophthalmology 1994;101:1871-82
90. (No authors listed). Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med 1998;339:300-306.
91. (No authors listed). Oral acyclovir for herpes simplex virus eye disease. Effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group. Arch Ophthalmol 2000;118:1030-6
92. Wilhelmus KR, Gee L, Hauck WW, et al. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994;101:1883-96
93. Greenhalgh T. How to read a paper: papers that summarise other papers (systematic reviews and meta-analyses. Br Med J 1997;315:672-5
94. (No authors listed). The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1979;121:1093-254
95. Guyatt G, Rennie D (eds). Users' Guides to the Medical Literature. A Manual for Evidence-Based Clinical Practice. Chicago, AMA Press, 2002
96. Wilhelmus KR. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 2007;24: CD002898.
97. Bell WR, Chulay JD, Feinberg JE. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204). Medicine (Baltimore) 1997;76:369-80
98. Gold J. The Albion Street Centre database, Sydney, Australia. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17 Suppl 1:S34-7
99. Samuel CE. Alitiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991;183:1-11
100. Cole SR, Chu H. Effect of acyclovir on herpetic ocular recurrence using a structural nested model. Contemp Clin Trials 2005;26:300-10
101. Chin G. Treatment of herpes simplex keratitis with idoxuridine and vidarabine: A double-blind study. Ann Ophthalmol 1978;10:1171-4